MD Pharmaceuticals, BioCell Promote BioCell Collagen to Orthopedic Doctors in Singapore

October 15, 2012

“Orthopedic doctors are prescribing MD Pharmaceuticals BioCell Collagen as a complement to traditional therapies and for post-surgical joint support, add Suhail Ishaq, BioCell Tehnologies’ president.

Health products marketer MD Pharmaceuticals and ingredients supplier BioCell Technologies jointly promoted branded ingredient BioCell Collagen to orthopedic doctors last week at the ASEAN Arthroplasty Association Meeting, one of the largest gatherings of orthopedic professionals in Singapore.

The companies sponsored a symposium titled “BioCell Collagen: A novel holistic dietary solution to joint and connective health tissue.”

“Glucosamine and chondroitin formulas have been used as the standard of care in joint health for more than two decades with limited success. The big question in the mind of health care practitioners today is what’s next in joint health,” said Melvin Wong, president of MD Pharmaceuticals. “I believe BioCell Collagen offers significant advantages with its advanced patented composition, which mirrors human articular cartilage and provides bioavailable collagen type II and hyaluronic acid for the comprehensive maintenance of healthy joint function.” MD Pharmaceuticals markets a product called BioCell Collagen (BCC). It is a prescription-only product available through general practitioners and orthopedic surgeons.

“Orthopedic doctors are prescribing MD Pharmaceuticals BioCell Collagen as a complement to traditional therapies and for post-surgical joint support, add Suhail Ishaq, BioCell Tehnologies’ president.